Eurican Herpes 205
Active substance
ATC code
Species
Dogs.
Indications
Active immunisation of pregnant bitches to prevent mortality, clinical signs and lesions in puppies resulting from canine herpes virus infections acquired in the first few days of life through passive immunity.
Onset of immunity: the passive immunity in puppies born from vaccinated bitches starts with sufficient colostrum intake.
Duration of immunity: first few days of life.
Dose to be administered and administration route
Subcutaneous route.
Following reconstitution of the powder with the solvent, inject one dose (1 ml) of the vaccine according to the following schedule:
First injection: Either during heat or 7 to 10 days after the presumed date of mating.
Second injection: 1 to 2 weeks before the expected date of whelping.
Revaccination: During each pregnancy, according to the same schedule.
The reconstituted content shall be a milky emulsion.
Adverse reactions
Dogs:
Common (1 to 10 animals / 100 animals treated): | Injection site swelling.1 |
Rare (1 to 10 animals / 10 000 animals treated): | Hypersensitivity reaction.2 |
1 Transient. Usually regressing within one week.
2 Appropriate symptomatic treatment should be administered.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 04491/5008 |
| EAN | 3661103006220 |
